Ceftazidimum [INN-Latin]

• Anti-Bacterial Agents
• ATC:J01DD02

• Ceftazidima [INN-Spanish]
• Ceftazidime Sodium In Plastic Container
• Ceftazidime pentahydrate
• Ceftazidimum [INN-Latin]
• Ceptaz
• Fortaz
• Fortaz In Plastic Container
• Pentacef
• Tazicef
• Tazidime
• Tazidime In Plastic Container

• No information avaliable

C₂₂H₂₂N₆O₇S₂

http://www.rxlist.com/cgi/generic2/ceftaz.htm

Ceftazidimum_[INN-Latin] FDA

Ceftazidimum_[INN-Latin] MSDS

No information avaliable

546.578 g/mol

No information avaliable

396 mg/L

Solid

-1.60

Powder; Powder for solution

For the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis).

Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic for parenteral administration. Ceftazidime is bactericidal in action exerting its effect by inhibition of enzymes responsible for cell-wall synthesis. A wide range of gram-negative organisms is susceptible to ceftazidime in vitro, including strains resistant to gentamicin and other aminoglycosides. In addition, ceftazidime has been shown to be active against gram-positive organisms. It is highly stable to most clinically important beta-lactamases, plasmid or chromosomal, which are produced by both gram-negative and gram-positive organisms and, consequently, is active against many strains resistant to ampicillin and other cephalosporins. Ceftazidime has activity against the gram-negative organisms Pseudomonas and Enterobacteriaceae. Its activity against Pseudomonas is a distinguishing feature of ceftazidime among the cephalosporins.

The absorption of ceftazidime is directly proportional to the size of the dose.

Ceftazidime overdosage has occurred in patients with renal failure. Reactions have included seizure activity, encephalopathy, asterixis, neuromuscular excitability, and coma.

No information avaliable

Enteric bacteria and other eubacteria